tm logo

Monitor this mark

View On USPTO

AZERA
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 29 Jun 2022

Last Applicant/ Owned by

PROGENICS PHARMACEUTICALS, INC.

47TH LOOR SUITE J

NEW YORK

NY

10007

Serial Number

85731453 filed on 18th Sep 2012

Registration Number

4898869 registered on 09th Feb 2016

in the Principal Register

Correspondent Address

OUGLAS R. WOL

OUGLAS R. WOL

600 ATLANTIC AVENUE

BOSTON, MA 02210

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

AZERA

Radiopharmaceutical compositions, namely, imaging and detection agents for treating neuro-endocrine cancers

Classification Information

Class [005]
Pharmaceutical Products

Radiopharmaceutical compositions, namely, imaging and detection agents for treating neuro-endocrine cancers

First Use Date in General

04th Dec 2015

First Use Date in Commerce

04th Dec 2015

Mark Details

Serial Number

No 85731453

Mark Type

No Service/Collective Mark

Attorney Docket Number

No P11762000000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
29th Jun 2022REGISTERE - SEC. 8 (6-YR) ACCEPTE & SEC. 15 ACK.
29th Jun 2022NOTICE O ACCEPTANCE O SEC. 8 & 15 - E-MAILE
22nd Jun 2022CASE ASSIGNE TO POST REGISTRATION PARALEGAL
13th Jan 2022TEAS SECTION 8 & 15 RECEIVE
09th Feb 2021COURTESY REMINER - SEC. 8 (6-YR) E-MAILE
13th Nov 2020TEAS CHANGE O OWNER ARESS RECEIVE
13th Nov 2020TEAS REVOKE/APP/CHANGE AR O ATTY/OM REP RECEIVE
13th Nov 2020ATTORNEY/OM.REP.REVOKE AN/OR APPOINTE
13th Nov 2020TEAS CHANGE O CORRESPONENCE RECEIVE
13th Nov 2020APPLICANT/CORRESPONENCE CHANGES (NON-RESPONSIVE) ENTERE